Insulet (PODD) Tops Q1 EPS by 17c; Guides

Insulet (NASDAQ: PODD) reported Q1 EPS of $0.40, $0.17 better than the analyst estimate of $0.23. Revenue for the quarter came in at $295.4 million versus the consensus estimate of $288.19 million.

GUIDANCE:

For the year ending December 31, 2022, the Company is reaffirming its expected revenue growth of 12% to 16%.

For earnings history and earnings-related data on Insulet (PODD) click here.

You May Also Be Interested In

• Attention Long-Term Shareholders of ARS Pharmaceuticals, Inc. (NASDAQ: SPRY); Bloom Energy Corporation (NYSE: BE); Erasca, Inc. (NASDAQ: ERAS); and Insulet Corporation (NASDAQ: PODD): Grabar Law Offic
• SVB & T Corporation (SVBT) Tops Q2 EPS by 275c
• Important Notice to Long-Term Shareholders of Bloom Energy Corporation (NYSE: BE); Cogent Communications Holdings, Inc. (NASDAQ: CCOI); Insulet Corporation (NASDAQ: PODD); and Primoris Services Corpor